However, 15 of the 19 risk loci that reached genome-wide significance for ER-negative disease in the meta-analysis showed some evidence of association (P<0.05) with breast cancer risk for BRCA1 mutation carriers using a retrospective likelihood analysis12. The gene discussed is BRCA1; the disease is breast carcinoma.